Holly Carlisle

Holly Carlisle is the VP of Translational Science at Latigo Biotherapeutics, Inc. Holly has a strong background in biology and neuroscience, having held various leadership positions at ESCAPE Bio and Amgen. Prior to their industry experience, Holly conducted postdoctoral research at Caltech and completed their doctoral dissertation at UCLA on the role of N-methyl-D-aspartate receptor-associated proteins in hippocampal plasticity. Holly's expertise lies in cross-functional project leadership for discovery phase programs related to neurodegeneration.